These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23090110)

  • 21. Sustained-release from layered matrix system comprising chitosan and xanthan gum.
    Phaechamud T; Ritthidej GC
    Drug Dev Ind Pharm; 2007 Jun; 33(6):595-605. PubMed ID: 17613024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
    Khan ZA; Tripathi R; Mishra B
    AAPS PharmSciTech; 2011 Dec; 12(4):1312-23. PubMed ID: 21969244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Native and microwave-modified Terminalia mantaly gums as sustained-release and bioadhesive excipients in naproxen matrix tablet formulations.
    Odeniyi MA; Oyedokun BM; Bamiro OA
    Polim Med; 2017; 47(1):35-42. PubMed ID: 29160627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of modified-release tablets of zolpidem tartrate by biphasic quick/slow delivery system.
    Mahapatra AK; Sameeraja NH; Murthy PN
    AAPS PharmSciTech; 2015 Jun; 16(3):579-88. PubMed ID: 25391273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Prosopis africana Seed Gum as an Extended Release Polymer for Tablet Formulation.
    Nadaf S; Nnamani P; Jadhav N
    AAPS PharmSciTech; 2015 Jun; 16(3):716-29. PubMed ID: 25523143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Terminalia gum as a directly compressible excipient for controlled drug delivery.
    Bamiro OA; Odeku OA; Sinha VR; Kumar R
    AAPS PharmSciTech; 2012 Mar; 13(1):16-23. PubMed ID: 22068290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of carboxymethylation on rheological and drug release characteristics of Terminalia catappa gum.
    Sharma R; Rana V
    Carbohydr Polym; 2017 Nov; 175():728-738. PubMed ID: 28917923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Valsartan Floating Matrix Tablets Using Low Density Polypropylene Foam Powder: In vitro and In vivo Evaluation.
    Rahamathulla M; Saisivam S; Gangadharappa HV
    AAPS PharmSciTech; 2019 Jan; 20(1):35. PubMed ID: 30604045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride.
    Bansal S; Beg S; Asthana A; Garg B; Asthana GS; Kapil R; Singh B
    Drug Deliv; 2016; 23(2):437-51. PubMed ID: 24865292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and in vitro analysis of floating matrix tablets of metronidazole using Brachystegia eurycoma gum.
    Ovenseri AC; Clifford O; Uwumagbe UM
    Pak J Pharm Sci; 2018 Jul; 31(4):1243-1249. PubMed ID: 30033407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
    Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
    Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and relevance of physicochemical interactions among components of a novel multiparticulate formulation for colonic delivery.
    Singh BN; Kim KH
    Int J Pharm; 2007 Aug; 341(1-2):143-51. PubMed ID: 17509782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and in vitro characterization of a non-effervescent floating drug delivery system for poorly soluble drug, glipizide.
    Meka VS; Pillai S; Dharmalingham SR; Sheshala R; Gorajana A
    Acta Pol Pharm; 2015; 72(1):193-204. PubMed ID: 25850215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and in vitro characterization of buccoadhesive tablets of timolol maleate.
    Gaikwad SS; Thombre SK; Kale YK; Gondkar SB; Darekar AB
    Drug Dev Ind Pharm; 2014 May; 40(5):680-90. PubMed ID: 24592893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the gum from Hakea gibbosa as a sustained-release and mucoadhesive component in buccal tablets.
    Alur HH; Pather SI; Mitra AK; Johnston TP
    Pharm Dev Technol; 1999 Aug; 4(3):347-58. PubMed ID: 10434280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, characterization of thiolated karaya gum and evaluation of effect of pH on its mucoadhesive and sustained release properties.
    Bahulkar SS; Munot NM; Surwase SS
    Carbohydr Polym; 2015 Oct; 130():183-90. PubMed ID: 26076615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release.
    Streubel A; Siepmann J; Bodmeier R
    Eur J Pharm Sci; 2003 Jan; 18(1):37-45. PubMed ID: 12554071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation.
    Khan FN; Dehghan MH
    AAPS PharmSciTech; 2011 Dec; 12(4):1077-86. PubMed ID: 21879394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.